MONTVALE, N.J., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Datascope Corp. (Nasdaq:DSCP) today announced that it will release its first quarter fiscal year 2009 financial results after the market closes on Thursday, November 6, 2008.
Datascope has previously announced that it has entered into a definitive agreement providing for the acquisition by Getinge AB, a global medical technology company with existing operations in the cardiac and vascular surgery markets, of all of the outstanding shares of Datascope Corp. common stock for $53.00 per share.
The transaction is subject to customary conditions, including the tender of a majority of the outstanding shares of Datascope common stock into the tender offer, regulatory approvals and the absence of a material adverse change with respect to Datascope Corp. Lawrence Saper, the Chairman and CEO of Datascope and an 18% stockholder, has entered into a voting and tender agreement in connection with this transaction.
About Datascope Corp.
Datascope Corp. is the global leader of intra-aortic balloon counterpulsation and a diversified medical device company that develops, manufactures and markets proprietary products for clinical health care markets in interventional cardiology, cardiovascular and vascular surgery and critical care. Datascope's products are sold throughout the world through direct sales representatives and independent distributors. Founded in 1964, Datascope is headquartered in Montvale, New Jersey. For news releases, webcasts and other company information, please visit Datascope's website, http://www.datascope.com.
The Datascope Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3953